SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-09-013980
Filing Date
2009-06-15
Accepted
2009-06-15 13:51:55
Documents
5
Effectiveness Date
2009-06-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE A14A c86743defa14a.htm DEFA14A 24920
2 GRAPHIC c86743c8674301.gif GRAPHIC 336
3 GRAPHIC c86743c8674302.gif GRAPHIC 335
4 GRAPHIC c86743c8674303.gif GRAPHIC 335
5 GRAPHIC c86743c8674304.gif GRAPHIC 336
  Complete submission text file 0000950123-09-013980.txt   28915
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-15070 | Film No.: 09891630
SIC: 2834 Pharmaceutical Preparations